Bellevue Group’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-21,700
| Closed | -$1.95M | – | 229 |
|
|
2020
Q1 | $1.95M | Sell |
21,700
-2,500
| -10% | -$225K | 0.04% | 130 |
|
|
2019
Q4 | $1.28M | Sell |
24,200
-1,600
| -6% | -$84.8K | 0.02% | 146 |
|
|
2019
Q3 | $1.02M | Buy |
+25,800
| New | +$1.02M | 0.02% | 144 |
|
|
2019
Q1 | – | Sell |
-14,300
| Closed | -$623K | – | 152 |
|
|
2018
Q4 | $623K | Sell |
14,300
-1,900
| -12% | -$82.8K | 0.04% | 127 |
|
|
2018
Q3 | $927K | Buy |
+16,200
| New | +$927K | 0.06% | 127 |
|